-
admin
Posts
Unique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market
Singapore-based Hilleman Laboratories, along with Bharat Biotech, confirm launch of new cholera vaccine, HILLCHOL® Success provides “template for the internationalization of future vaccine and biologics...
Aghanim and Adyen Form Strategic Partnership to Power Direct-to-Consumer Payments for Mobile Games
LOS ANGELES, Aug. 28, 2024 /PRNewswire/ — Aghanim, a mobile gaming fintech company founded by the former CEO and CTO of Xsolla, today announces a strategic...
Cosmetic Peptide Synthesis Market is Anticipated to Reach US$ 425.6 Million by 2034, Growing at a 5.7% CAGR | Fact.MR Report
Rising Use of Cosmetic Peptide Synthesis Products in Premium Anti-aging Formulations Due to Their Ability to Boost Collagen Production. Rockville, MD, Aug. 27, 2024 (GLOBE...
Liberty Bank, N.A. Relocates to New Gateway at Millbrae Station Community
MILLBRAE, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) — On August 26, Liberty Bank, N.A. celebrated the opening of its new Millbrae Branch in the Gateway...
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
Providence, RI, Aug. 27, 2024 (GLOBE NEWSWIRE) — Ocean Biomedical (NASDAQ:OCEA) announced today that its Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been issued...
SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference
JERSEY CITY, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and...
Korro to Participate in Upcoming September Investor and Scientific Conferences
CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) — Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic...
Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
PDUFA target action date set for December 27, 2024 FDA currently plans to hold an Advisory Committee meeting REDWOOD CITY, Calif., Aug. 27, 2024 (GLOBE...
Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study
Milestone Achievement Advances Commercialization Timeline for DeepView™ System for Burn Indication DALLAS, Aug. 27, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI”...
Xuan Wu Cloud Announces Interim Results for 2024
Revenue Increased by 22.2% and Net Loss Reduced by Nearly 70% year-on-year In the first half of 2024, Xuan Wu Cloud achieved total revenue of...
